TAM
FBIO icon

Titleist Asset Management’s Fortress Biotech FBIO Stock Holding History

Titleist Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,000
Closed -$39.1K – 328
2025
Q2 		$39.1K Hold
21,000
– – ﹤0.01% 318
2025
Q1 		$32.8K Hold
21,000
– – ﹤0.01% 294
2024
Q4 		$42.5K Sell
21,000
-18,000
-46% -$32.6K ﹤0.01% 306
2024
Q3 		$56.4K Sell
39,000
-1,080
-3% -$2.06K 0.01% 275
2024
Q2 		$68.5K Buy
+40,080
New +$72.7K 0.01% 257

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Titleist Asset Management's FBIO Position: Q3 2025 in Review

Titleist Asset Management sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 21,000 shares — an estimated $39.1K sold.

Titleist Asset Management first reported a position in FBIO in Q2 2024 and held it in 5 quarters. The position peaked at $68.5K in Q2 2024. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Titleist Asset Management reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Titleist Asset Management sold 21,000 Fortress Biotech shares in Q3 2025, an estimated $39.1K.
  • Titleist Asset Management first reported a position in Fortress Biotech in Q2 2024 and held it in 5 quarters.
  • Titleist Asset Management's Fortress Biotech position peaked at $68.5K in Q2 2024.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Titleist Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.